The Company has announced eight recalls involving millions of bottles of nonprescription medicines since last September. They involved products made at factories in Pennsylvania and Puerto Rico. Now the Company, which has come under scrutiny for quality problems with its drug units, is starting to experience similar problems with its device divisions. DePuy Orthopaedics, a J&J company, last week announced a recall of some hip-replacement devices that appear to fail excessively. DePuy also received a warning letter citing it for marketing the TruMatch Personalized Solutions System in the U.S. without clearance or approval.
Quality is one of the six key intangible assets that underlie the value of reputation. (The other five are ethics, innovation, safety, sustainability, and security). Increasing, protecting, and restoring the value of these assets, you might say, is a company’s Mission:Intangible.
This is why. The Steel City Re Corporate Reputation Index, which tracks the financial consequences of intangible asset management, shows that over the trailing twelve months, Johnson & Johnson’s ranking dropped from the 93rd to the 88th percentile relative to the 28 companies in the Major Pharmaceuticals sector. As is often the case with a deteriorating reputation profile, the Company has underperformed the median of this sector this past year by nearly 13%.

The numbers show three other trends. The Company is large with a long history and used to hold the number one reputation rank in this sector, and according to some surveys, among all companies. That standing has provided resilience, but has not been able to arrest the slow and steady decline evidenced by the low volatility. That loss comes almost exclusively from an impairment of the Company’s intangible assets. Whereas a year ago, the Company’s intangibles comprised 91% of the firms market value – right in line with the median of the sector – today that fraction has dropped to less than 88%. All this comes amidst challenges for the industry as a whole, whose reputational standing relative to all companies has also declined from the 91st to the 88th percentile.

With all this going on, Mr. Shetty, a vice president, will have his hands full. And his work will have little impact on enterprise value (and potential derivative law suits and D&O claims) unless signals start emanating from even higher levels that the Company’s credo – written by General Johnson himself – has been once again found and will be honored to the letter. Attention Board of Directors! Are you listening?
Comments
Post has no comments.